2,2'-azobis(2-amidinopropane) has been researched along with Hypercholesterolemia in 2 studies
2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simon, E | 1 |
| Paul, JL | 1 |
| Soni, T | 1 |
| Simon, A | 1 |
| Moatti, N | 1 |
| Hussein, O | 1 |
| Schlezinger, S | 1 |
| Rosenblat, M | 1 |
| Keidar, S | 1 |
| Aviram, M | 1 |
2 other studies available for 2,2'-azobis(2-amidinopropane) and Hypercholesterolemia
| Article | Year |
|---|---|
Plasma and erythrocyte vitamin E content in asymptomatic hypercholesterolemic subjects.
Topics: Amidines; Cholesterol; Cholesterol, LDL; Chromatography, High Pressure Liquid; Erythrocytes; Hemolys | 1997 |
Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL.
Topics: Adult; Aged; Amidines; Anticholesteremic Agents; Copper Sulfate; Dose-Response Relationship, Drug; F | 1997 |